• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of thymic selection on T cell recognition of foreign and tumor antigenic peptides.胸腺选择对 T 细胞识别外来和肿瘤抗原肽的影响。
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E7875-E7881. doi: 10.1073/pnas.1708573114. Epub 2017 Sep 5.
2
The present status and future prospects of peptide-based cancer vaccines.基于肽的癌症疫苗的现状与未来前景。
Int Immunol. 2016 Jul;28(7):319-28. doi: 10.1093/intimm/dxw027. Epub 2016 May 28.
3
Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies.病毒和肿瘤特异性 T 细胞受体的不同亲和窗口:对治疗策略的影响。
Eur J Immunol. 2012 Dec;42(12):3174-9. doi: 10.1002/eji.201242606. Epub 2012 Oct 16.
4
Harnessing the power of Vδ2 cells in cancer immunotherapy.利用Vδ2细胞在癌症免疫治疗中的作用。
Clin Exp Immunol. 2015 Apr;180(1):1-10. doi: 10.1111/cei.12564.
5
Development of lymphopoiesis as a function of the thymic microenvironment. Use of CD8+ cytotoxic T lymphocytes for cellular immunotherapy of human cancer.作为胸腺微环境功能的淋巴细胞生成的发展。CD8 + 细胞毒性T淋巴细胞在人类癌症细胞免疫治疗中的应用。
In Vivo. 1994 Nov-Dec;8(5):915-43.
6
The role of neoantigens in response to immune checkpoint blockade.新抗原在免疫检查点阻断反应中的作用。
Int Immunol. 2016 Aug;28(8):411-9. doi: 10.1093/intimm/dxw019. Epub 2016 Apr 5.
7
T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells.T细胞受体结合亲和力决定癌症特异性CD8+ T细胞的功能特征。
Clin Exp Immunol. 2015 May;180(2):255-70. doi: 10.1111/cei.12570.
8
Self-peptides in TCR repertoire selection and peripheral T cell function.T 细胞受体库选择和外周 T 细胞功能中的自身肽。
Curr Top Microbiol Immunol. 2014;373:49-67. doi: 10.1007/82_2013_319.
9
The effects of thymic selection on the range of T cell cross-reactivity.胸腺选择对T细胞交叉反应范围的影响。
Eur J Immunol. 2005 Dec;35(12):3452-9. doi: 10.1002/eji.200535098.
10
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.鉴定具有 CD4+ 和 CD8+ T 细胞表位的混杂 KIF20A 长肽:恶性肿瘤患者中 KIF20A 特异性 CD4+ T 细胞免疫。
Clin Cancer Res. 2013 Aug 15;19(16):4508-20. doi: 10.1158/1078-0432.CCR-13-0197. Epub 2013 May 28.

引用本文的文献

1
AI/ML-empowered approaches for predicting T Cell-mediated immunity and beyond.用于预测T细胞介导免疫及其他方面的人工智能/机器学习赋能方法。
Front Immunol. 2025 Aug 29;16:1651533. doi: 10.3389/fimmu.2025.1651533. eCollection 2025.
2
Biophysical modeling for accurate T cell specificity prediction of viral and tumor antigens.用于准确预测病毒和肿瘤抗原T细胞特异性的生物物理建模。
bioRxiv. 2025 May 28:2025.05.25.655924. doi: 10.1101/2025.05.25.655924.
3
Feature selection enhances peptide binding predictions for TCR-specific interactions.特征选择增强了对TCR特异性相互作用的肽结合预测。
Front Immunol. 2025 Jan 23;15:1510435. doi: 10.3389/fimmu.2024.1510435. eCollection 2024.
4
Integration of kinetic data into affinity-based models for improved T cell specificity prediction.将动力学数据整合到基于亲和力的模型中以改进T细胞特异性预测。
Biophys J. 2024 Dec 3;123(23):4115-4122. doi: 10.1016/j.bpj.2024.11.002. Epub 2024 Nov 8.
5
Feature Selection Enhances Peptide Binding Predictions for TCR-Specific Interactions.特征选择增强了TCR特异性相互作用的肽结合预测。
bioRxiv. 2024 Oct 13:2024.10.11.617901. doi: 10.1101/2024.10.11.617901.
6
Focusing on CD8 T-cell phenotypes: improving solid tumor therapy.聚焦 CD8 T 细胞表型:改善实体瘤治疗。
J Exp Clin Cancer Res. 2024 Sep 28;43(1):266. doi: 10.1186/s13046-024-03195-5.
7
The role of promiscuous molecular recognition in the evolution of RNase-based self-incompatibility in plants.在植物中基于 RNase 的自我不亲和性的进化中,混杂分子识别的作用。
Nat Commun. 2024 Jun 7;15(1):4864. doi: 10.1038/s41467-024-49163-7.
8
RACER-m leverages structural features for sparse T cell specificity prediction.RACER-m 利用结构特征进行稀疏 T 细胞特异性预测。
Sci Adv. 2024 May 17;10(20):eadl0161. doi: 10.1126/sciadv.adl0161. Epub 2024 May 15.
9
How persistent infection overcomes peripheral tolerance mechanisms to cause T cell-mediated autoimmune disease.持续性感染如何克服外周耐受机制导致 T 细胞介导的自身免疫性疾病。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2318599121. doi: 10.1073/pnas.2318599121. Epub 2024 Mar 6.
10
Quantitative approaches for decoding the specificity of the human T cell repertoire.解析人类 T 细胞受体特异性的定量方法。
Front Immunol. 2023 Sep 7;14:1228873. doi: 10.3389/fimmu.2023.1228873. eCollection 2023.

本文引用的文献

1
Neoantigen landscape dynamics during human melanoma-T cell interactions.人类黑色素瘤 T 细胞相互作用过程中的新抗原景观动态
Nature. 2016 Aug 4;536(7614):91-5. doi: 10.1038/nature18945. Epub 2016 Jun 27.
2
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.利用供体来源的 T 细胞受体库靶向癌症新生抗原。
Science. 2016 Jun 10;352(6291):1337-41. doi: 10.1126/science.aaf2288. Epub 2016 May 19.
3
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.克隆性新抗原引发T细胞免疫反应性以及对免疫检查点阻断的敏感性。
Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3.
4
The IPD-IMGT/HLA Database - New developments in reporting HLA variation.国际前瞻性数据库-IMGT/HLA数据库:HLA变异报告的新进展。
Hum Immunol. 2016 Mar;77(3):233-237. doi: 10.1016/j.humimm.2016.01.020. Epub 2016 Jan 27.
5
Tumor neoantigens: building a framework for personalized cancer immunotherapy.肿瘤新抗原:构建个性化癌症免疫治疗的框架
J Clin Invest. 2015 Sep;125(9):3413-21. doi: 10.1172/JCI80008. Epub 2015 Aug 10.
6
Neoantigens in cancer immunotherapy.肿瘤免疫治疗中的新生抗原
Science. 2015 Apr 3;348(6230):69-74. doi: 10.1126/science.aaa4971.
7
Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see).T 细胞库的阳性和阴性选择:胸腺细胞所见(及所不见)。
Nat Rev Immunol. 2014 Jun;14(6):377-91. doi: 10.1038/nri3667. Epub 2014 May 16.
8
Theories and quantification of thymic selection.胸腺选择的理论与量化
Front Immunol. 2014 Feb 4;5:13. doi: 10.3389/fimmu.2014.00013. eCollection 2014.
9
Estimating the diversity, completeness, and cross-reactivity of the T cell repertoire.评估T细胞受体库的多样性、完整性和交叉反应性。
Front Immunol. 2013 Dec 26;4:485. doi: 10.3389/fimmu.2013.00485.
10
Breakthrough of the year 2013. Cancer immunotherapy.2013年度重大突破。癌症免疫疗法。
Science. 2013 Dec 20;342(6165):1432-3. doi: 10.1126/science.342.6165.1432.

胸腺选择对 T 细胞识别外来和肿瘤抗原肽的影响。

Effects of thymic selection on T cell recognition of foreign and tumor antigenic peptides.

机构信息

Center for Theoretical Biological Physics, Rice University, Houston, TX 77005;

Department of Bioengineering, Rice University, Houston, TX 77005.

出版信息

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E7875-E7881. doi: 10.1073/pnas.1708573114. Epub 2017 Sep 5.

DOI:10.1073/pnas.1708573114
PMID:28874554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5617294/
Abstract

The advent of cancer immunotherapy has generated renewed hope for the treatment of many malignancies by introducing a number of novel strategies that exploit various properties of the immune system. These therapies are based on the idea that cytotoxic T lymphocytes (CTLs) directly recognize and respond to tumor-associated neoantigens (TANs) in much the same way as they would to foreign peptides presented on cell surfaces. To date, however, nearly all attempts to optimize immunotherapeutic strategies have been empirical. Here, we develop a model of T cell selection based on the assumption of random interaction strengths between a self-peptide and the various T cell receptors. The model enables the analytical study of the effects of selection on the CTL recognition of TANs and completely foreign peptides and can estimate the number of CTLs that can detect donor-matched transplants. We show that negative selection thresholds chosen to reflect experimentally observed thymic survival rates result in near-optimal production of T cells that are capable of surviving selection and recognizing foreign antigen. These analytical results are confirmed by simulation.

摘要

癌症免疫疗法的出现为治疗许多恶性肿瘤带来了新的希望,它引入了许多新的策略,利用了免疫系统的各种特性。这些疗法的基础是细胞毒性 T 淋巴细胞 (CTL) 能够直接识别和响应肿瘤相关的新抗原 (TAN),就像它们识别细胞表面上呈现的外来肽一样。然而,迄今为止,几乎所有优化免疫治疗策略的尝试都是经验性的。在这里,我们基于自我肽和各种 T 细胞受体之间的随机相互作用强度的假设,建立了 T 细胞选择的模型。该模型能够对选择对 CTL 识别 TAN 和完全外来肽的影响进行分析研究,并能够估计能够检测到与供体匹配的移植的 CTL 的数量。我们表明,选择以反映实验观察到的胸腺存活率的负选择阈值导致能够在选择中存活并识别外来抗原的 T 细胞的近乎最佳产生。这些分析结果通过模拟得到了证实。